Psychopharmacology pipeline intelligence
Psychopharmacology, in focus.
CNS Pulse tracks the CNS drug-development pipeline and reports from the field — starting with full coverage of conference abstracts, searchable by author, session, and meeting.
Pipeline intelligence
Compounds108
CNS molecules in development — mechanism, phase, and trial evidence.
Indications38
The pipeline by condition, MeSH/ICD-11 coded with subtype hierarchy.
Companies58
Sponsors developing CNS drugs, with ticker, HQ, and pipeline phase.
Targets92
Molecular targets, with every compound in development that acts on each.
Readouts
The catalyst calendar — anticipated and reported trial readouts.
Investigators15
Investigators running trials on tracked compounds, by recruiting activity.
Tracking 149 programs (compound × indication) across 108 compounds.
Conference reports
Conferences1
Structured abstracts by meeting, indexed by session.
Abstracts410
Every published abstract, searchable across meetings.
Authors320
Presenting authors, with their abstracts collected.
Articles
Long-form clinical analysis and commentary.
Coming soon
Conferences